514 668

Cited 0 times in

전립선암의 호르몬 불응성과 PTEN, CD44발현 양상의 연관성 분석

DC Field Value Language
dc.contributor.author조강수-
dc.contributor.author최영득-
dc.contributor.author함원식-
dc.contributor.author홍성준-
dc.date.accessioned2014-12-19T17:24:37Z-
dc.date.available2014-12-19T17:24:37Z-
dc.date.issued2012-
dc.identifier.issn2234-4977-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/91355-
dc.description.abstractPurpose: Most prostate cancers (PCs) ultimately progress to castration resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT). Because cancer stem cells survive ADT, which can lead to tumor recurrence and understanding the molecular changes that occur after ADT would helpful for finding novel therapies targeting CRPC, we analyzed the expression of CD44, a stem cell marker in radical prostatectomy samples after ADT. Materials and Methods: PTEN and CD44 expression profiles were determined by microarray or real-time PCR in 107 radical prostatectomy specimens from patients given neoadjuvant ADT. Pathological regressive changes and the correlation of postoperative biochemical failure with PTEN and CD44 expression were analyzed. Results: As the PC tissues had minimal regression effects after ADT, they showed significantly advanced pathological stage (p=0.001), PTEN inactivation (p<0.001), and high CD44 expression (p<0.001). The PTEN inactivation group showed a significantly higher probability of positive CD44 expression compared to the non-PTEN inactivation group (OR 10.5, 95% CI 4.0 to 27.6, p<0.001). Cox regression analysis revealed that seminal vesicle invasion, biopsy Gleason score, and CD44 expression were significantly associated with the time to biochemical recurrence. Conclusions: PC tissues refractory to ADT showed PTEN inactivation with high CD44 expression. The PTEN inactivation group showed a significantly high probability of positive CD44 expression. Our results support that the PTEN/PI3K/Akt pathways are necessary for prostate cancer stem cell maintenance.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean Journal of Urological Oncology-
dc.publisherKorean Journal of Urological Oncology-
dc.relation.isPartOfKorean Journal of Urological Oncology-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title전립선암의 호르몬 불응성과 PTEN, CD44발현 양상의 연관성 분석-
dc.title.alternativeThe Analysis of Relationship between Refractoriness to Androgen Deprivation and PTEN, CD44 Expression in Prostate Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Urology (비뇨기과학)-
dc.contributor.googleauthor함원식-
dc.contributor.googleauthor박재원-
dc.contributor.googleauthor조강수-
dc.contributor.googleauthor이창기-
dc.contributor.googleauthor최영득-
dc.contributor.googleauthor홍성준-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03801-
dc.contributor.localIdA04111-
dc.contributor.localIdA04337-
dc.contributor.localIdA04402-
dc.relation.journalcodeJ02133-
dc.identifier.eissn2233-5633-
dc.identifier.pmidProstate neoplasms ; PTEN ; PI3K/Akt ; CD44-
dc.subject.keywordProstate neoplasms-
dc.subject.keywordPTEN-
dc.subject.keywordPI3K/Akt-
dc.subject.keywordCD44-
dc.contributor.alternativeNameCho, Kang Su-
dc.contributor.alternativeNameChoi, Young Deuk-
dc.contributor.alternativeNameHam, Won Sik-
dc.contributor.alternativeNameHong, Sung Joon-
dc.contributor.affiliatedAuthorCho, Kang Su-
dc.contributor.affiliatedAuthorChoi, Young Deuk-
dc.contributor.affiliatedAuthorHam, Won Sik-
dc.contributor.affiliatedAuthorHong, Sung Joon-
dc.citation.volume10-
dc.citation.number1-
dc.citation.startPage21-
dc.citation.endPage26-
dc.identifier.bibliographicCitationKorean Journal of Urological Oncology, Vol.10(1) : 21-26, 2012-
dc.identifier.rimsid30130-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.